Capstan Medical, which is developing heart valve implants with a robotic delivery platform, said Wednesday it has secured $110 million in new funding to advance its work leading to upcoming pivotal ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Capstan Medical says it has notched a first in the ...

The company offers surgical robotics with catheter-based technology and implants to repair and replace heart valves. It will use the funds to advance its reach within healthcare. "Percutaneous ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Santa Cruz startup Capstan ...

Capstan Medical has raised $110 million in a series C round to bring its robotic-enabled minimally invasive solutions to address heart valve disease to market. This follows a $31.4 million round the ...